Association between hearing loss and hereditary ATTR amyloidosis

References

• Finsterer J, Iglseder S, Wanschitz J, et al. Hereditary transthyretin-related amyloidosis. Acta Neurol Scand. 2019;139(2):92–105.
   PubMed Web of Science ®Google Scholar
• Adams D, Cauquil C, Labeyrie C. Familial amyloid polyneuropathy. Curr Opin Neurol. 2017;30(5):481–489.
   PubMed Web of Science ®Google Scholar
• Flodrova P, Flodr P, Pika T, et al. Cardiac amyloidosis: from clinical suspicion to morphological diagnosis. Pathology. 2018;50(3):261–268.
   PubMed Web of Science ®Google Scholar
• Gillmore JD, Damy T, Fontana M, et al. A new staging system for cardiac transthyretin amyloidosis. Eur Heart J. 2018;39(30):2799–2806.
   PubMed Web of Science ®Google Scholar
• Sekijima Y. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments. J Neurol Neurosurg Psychiatry. 2015;86(9):1036–1043.
   PubMed Web of Science ®Google Scholar
• Samões R, Taipa R, Valdrez K, et al. Amyloid detection in the transverse carpal ligament of patients with hereditary ATTR V30M amyloidosis and carpal tunnel syndrome. Amyloid. 2017;24(2):73–77.
   PubMed Web of Science ®Google Scholar
• Sekijima Y, Hammarström P, Matsumura M, et al. Energetic characteristics of the new transthyretin variant A25T may explain its atypical central nervous system pathology. Lab Invest. 2003;83(3):409–417.
   PubMed Web of Science ®Google Scholar
• Béquignon E, Guellich A, Barthier S, et al. How your ears can tell what is hidden in your heart: wild-type transthyretin amyloidosis as potential cause of sensorineural hearing loss inelderly-AmyloDEAFNESS pilot study. Amyloid. 2017;24(2):96–100.
   PubMed Web of Science ®Google Scholar
• Lossos A, Soffer D, Steiner-Birmanns B, et al. Extended phenotype in the transthyretin Tyr77 familial amyloid polyneuropathy. Eur Neurol. 2005;53(2):55–59.
   PubMed Web of Science ®Google Scholar
• Meng L-C, Lyu H, Zhang W, et al. Hereditary transthyretin amyloidosis in eight Chinese families. Chin Med J. 2015;128(21):2902–2905.
   PubMed Web of Science ®Google Scholar
• Maurer MS, Schwartz JH, Gundapaneni B, et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med. 2018;379(11):1007–1016.
   PubMed Web of Science ®Google Scholar
• Bodez D, Ternacle J, Guellich A, et al. Prognostic value of right ventricular systolic function in cardiac amyloidosis. Amyloid. 2016;23(3):158–167.
   PubMed Web of Science ®Google Scholar
• Wechalekar AD, Gillmore JD, Hawkins PN. Systemic amyloidosis. Lancet. 2016;387(10038):2641–2654.
   PubMed Web of Science ®Google Scholar
• Gillmore JD, Maurer MS, Falk RH, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016;133(24):2404–2412.
   PubMed Web of Science ®Google Scholar
• Bureau International d’audiophonologie. Recommandation biap 02/1 bis: Classification audiométrique des déficiences auditives; Lisbonne; 1997.
   Google Scholar
• Direction de la recherche, des études, de l’évaluation et des statistiques (DREES). Vivre avec des difficultés d’audition. 2014.
   Google Scholar
• Klein CJ, Nakumura M, Jacobson DR, et al. Transthyretin amyloidosis (serine 44) with headache, hearing loss, and peripheral neuropathy. Neurology. 1998;51(5):1462–1464.
   PubMed Web of Science ®Google Scholar
• Kiuru S. Familial amyloidosis of the Finnish type (FAF). A clinical study of 30 patients. Acta Neurol Scand. 1992;86(4):346–353.
   PubMed Web of Science ®Google Scholar
• Brett M, Persey MR, Reilly MM, et al. Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis. Brain J Neurol. 1999;122(Pt 2):183–190.
   Google Scholar
• Garzuly F, Vidal R, Wisniewski T, et al. Familial meningocerebrovascular amyloidosis, Hungarian type, with mutant transthyretin (TTR Asp18Gly). Neurology. 1996;47(6):1562–1567.
   PubMed Web of Science ®Google Scholar
• Katsarkas A, Ayukawa H. Hearing loss due to aging (presbycusis). J Otolaryngol. 1986;15(4):239–244.
   PubMedGoogle Scholar
• Omata Y, Tharasegaran S, Lim Y-M, et al. Expression of amyloid-β in mouse cochlear hair cells causes an early-onset auditory defect in high-frequency sound perception. Aging. 2016;8(3):427–439.
   PubMedGoogle Scholar
• Arlinger S. Audiometric profile in presbycusis. Acta Otolaryngol Suppl. 1990;476:85–89.
   PubMedGoogle Scholar
• Koike H, Ikeda S, Takahashi M, et al. Schwann cell and endothelial cell damage in transthyretin familial amyloid polyneuropathy. Neurology. 2016;87(21):2220–2229.
   PubMed Web of Science ®Google Scholar
• Panza F, Solfrizzi V, Seripa D, et al. Age-related hearing impairment and frailty in Alzheimer’s disease: interconnected associations and mechanisms. Front Aging Neurosci. 2015;7:113.
   PubMed Web of Science ®Google Scholar
• Sinha UK, Hollen KM, Rodriguez R, et al. Auditory system degeneration in Alzheimer's disease. Neurology. 1993;43(4):779–785.
   PubMed Web of Science ®Google Scholar
• Helzner EP, Cauley JA, Pratt SR, et al. Race and sex differences in age-related hearing loss: the Health, Aging and Body Composition Study. J Am Geriatr Soc. 2005;53(12):2119–2127.
   PubMed Web of Science ®Google Scholar
• Roth TN, Hanebuth D, Probst R. Prevalence of age-related hearing loss in Europe: a review. Eur Arch Otorhinolaryngol.. 2011;268(8):1101–1107.
   PubMed Web of Science ®Google Scholar
• Van Eyken E, Van Camp G, Van Laer L. The complexity of age-related hearing impairment: contributing environmental and genetic factors. Audiol Neurotol. 2007;12(6):345–358.
   PubMed Web of Science ®Google Scholar